Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30024501HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30024502HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30024503HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30024504HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30024505HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30024506HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS20002072HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS20005932HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS20009180HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS20007348HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TCGA Plot Options
Drug Information
GeneDPYD
DrugBank IDDB03516
Drug NameEniluracil
Target IDBE0000960
UniProt IDQ12882
Regulation Type
PubMed IDs16466986
CitationsCzito BG, Hong TJ, Cohen DP, Petros WP, Tyler DS, Pappas TN, Yu D, Lee CG, Lockhart AC, Morse MA, Fernando N, Hurwitz HI: A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract. Cancer Invest. 2006 Feb;24(1):9-17.
GroupsInvestigational
Direct ClassificationPyrimidones
SMILESO=C1NC=C(C#C)C(=O)N1
Pathways
PharmGKB
ChEMBLCHEMBL355200